| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$2,796 ) |
| | 2023 | 2021 | TRADEWIND BIOSCIENCE, INC. | 38 MORNINGSIDE DR | DALY CITY | CA | 94015-4509 | SAN MATEO | USA | R41CA250757 | Development of a Therapeutic Monoclonal Antibody Against EGFL6, a Mediator of Tumor Growth and Metastasis | 000 | 1 | NIH | 8/11/2023 | -$2,796 |
|
| Issue Date FY: 2021 ( Subtotal = $405,552 ) |
| | 2021 | 2021 | TRADEWIND BIOSCIENCE, INC. | 38 MORNINGSIDE DR | DALY CITY | CA | 94015-4509 | SAN MATEO | USA | R41CA250757 | Development of a Therapeutic Monoclonal Antibody Against EGFL6, a Mediator of Tumor Growth and Metastasis | 000 | 1 | NIH | 4/19/2021 | $405,552 |
|
|
